23 October, 2025
Denovo Sciences, Sidra Medicine, and Weill Cornell Medicine-Qatar Announce Collaboration to Discover Drug Candidates for Homocystinuria
Denovo Sciences Inc., a pioneer in AI-driven drug discovery based on synthetic data, Weill Cornell Medicine-Qatar (WCM-Q), a leading biomedical research and educational institution, and Sidra Medicine, a women’s and children’s healthcare organization, are engaging in a collaboration to identify and develop novel drug candidates for homocystinuria, a rare and genetic metabolic disorder.
